WO2011005043A3 - Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract - Google Patents

Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract Download PDF

Info

Publication number
WO2011005043A3
WO2011005043A3 PCT/KR2010/004455 KR2010004455W WO2011005043A3 WO 2011005043 A3 WO2011005043 A3 WO 2011005043A3 KR 2010004455 W KR2010004455 W KR 2010004455W WO 2011005043 A3 WO2011005043 A3 WO 2011005043A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
prevention
treatment
virus infection
influenza virus
Prior art date
Application number
PCT/KR2010/004455
Other languages
French (fr)
Korean (ko)
Other versions
WO2011005043A2 (en
Inventor
이우송
노문철
박수진
류영배
장종선
정형재
권형준
Original Assignee
한국생명공학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020090085112A external-priority patent/KR101077920B1/en
Application filed by 한국생명공학연구원 filed Critical 한국생명공학연구원
Priority to US13/383,132 priority Critical patent/US8545903B2/en
Priority to CN201080030907.2A priority patent/CN102573870B/en
Publication of WO2011005043A2 publication Critical patent/WO2011005043A2/en
Publication of WO2011005043A3 publication Critical patent/WO2011005043A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a composition for the prevention and treatment of influenza virus infection and a composition for suppressing neuraminidase activity comprising turmeric extract. Turmeric extract and turmeric fractions and curcuminoid compounds isolated therefrom exhibit an effect in suppressing neuraminidase activity, and simultaneously exhibit a virucidal and a cytopathy suppressing effect against various influenza viruses and can therefore be used advangageously in the prevention and treatment of influenza virus infection.
PCT/KR2010/004455 2009-07-08 2010-07-08 Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract WO2011005043A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US13/383,132 US8545903B2 (en) 2009-07-08 2010-07-08 Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract
CN201080030907.2A CN102573870B (en) 2009-07-08 2010-07-08 Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20090062321 2009-07-08
KR10-2009-0062321 2009-07-08
KR1020090085112A KR101077920B1 (en) 2009-07-08 2009-09-09 Composition for prevention and treatment of influenza virus and composition for inhibiting the activity of neuraminidase comprising extracts of Turmeric
KR10-2009-0085112 2009-09-09

Publications (2)

Publication Number Publication Date
WO2011005043A2 WO2011005043A2 (en) 2011-01-13
WO2011005043A3 true WO2011005043A3 (en) 2011-08-25

Family

ID=43429688

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/004455 WO2011005043A2 (en) 2009-07-08 2010-07-08 Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract

Country Status (1)

Country Link
WO (1) WO2011005043A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070102487A (en) * 2004-12-14 2007-10-18 더 퀴글리 코포레이션 Compositions and methods for reducing the transmissivity of illnesses
JP2008280333A (en) * 2007-04-10 2008-11-20 Yoshinari Matsui Medicinal composition for treating terminal cancer and so on

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070102487A (en) * 2004-12-14 2007-10-18 더 퀴글리 코포레이션 Compositions and methods for reducing the transmissivity of illnesses
JP2008280333A (en) * 2007-04-10 2008-11-20 Yoshinari Matsui Medicinal composition for treating terminal cancer and so on

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GUDDADARANGAVVANAHALLY K. JAYAPRAKASHA, LINGAMULLU JAGAN MOHAN RAO, AND KUNNUMPURATH K. SAKARIAH: "Improved HPLC Method for the Determination of Curcumin, Demethoxycurcumin, and Bisdemethoxycurcumin", J. AGRIC. FOOD CHEM., vol. 50, no. 13, 2002, pages 3668 - 3672 *

Also Published As

Publication number Publication date
WO2011005043A2 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
IL244597B (en) Inhibitors of influenza viruses replication, compositions comprising the same and uses thereof
WO2008133704A3 (en) Antimicrobial and antiviral compounds and methods for their use
MD4589B1 (en) Pharmaceutical composition comprising sofosbuvir and uses thereof for treating hepatitis C virus
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
WO2012083048A3 (en) Anti-viral compounds
BR112013020425A2 (en) compositions and methods for the treatment or prevention of hepatitis B virus infection
IL186611A0 (en) Vaccine against pandemic strains of influenza viruses
WO2012083053A3 (en) Anti-viral compounds
WO2012144754A3 (en) Composition containing a galla rhois extract having virus inhibitory effects or a compound isolated therefrom as an active ingredient, and uses thereof
AP3031A (en) Avian influenza viruses, compositions, formulations, and methods
WO2008147496A3 (en) Neuraminidase-deficient live influenza vaccines
WO2012083061A3 (en) Anti-viral compounds
EP2538946A4 (en) Anti-viral formulations
WO2012093234A3 (en) Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus
SG179082A1 (en) Method for the preparation of an influenza virus
WO2011150190A3 (en) Hcv inhibitor compounds and methods of use thereof
WO2012083058A3 (en) Anti-viral compounds
WO2011049348A3 (en) Antiviral agents obtained from curcuma longa, having inhibitory activities against avian influenza, swine influenza, and novel influenza
EP2910563A8 (en) Triterpene derivative and its anti-influenza use
WO2011076367A3 (en) Synergistic antiviral composition and use thereof
WO2017078577A3 (en) Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases
EP2788311A4 (en) A composition comprising the extract of pine tree leaf or the compounds isolated therefrom for the prevention and treatment of cancer disease by inhibiting hpv virus and the uses thereby
WO2012162580A3 (en) Anti-viral compounds
WO2012134169A3 (en) Composition for lung cancer treatment and functional food containing gleditsiae semen extract
WO2011098778A8 (en) Peptides for vaccines against birch allergy

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080030907.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10797317

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13383132

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 10797317

Country of ref document: EP

Kind code of ref document: A2